BMRN vs TNYA · P/E 40, rev $1.76B vs rev $1.3M
Biomarin Pharmaceutical Inc (BMRN) versus Tenaya Therapeutics Inc (TNYA) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Tenaya Therapeutics Inc (TNYA) is a biotechnology company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TNYA revenue for 2026-06-30 was $1.3M. Net income was -$62.7M. TNYA currently screens at market cap $156.0M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TNYA currently screens at market cap $156.0M.
Not investment advice. Open the BMRN and TNYA stock pages for the full models.
Not investment advice.